April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Rapid And Substantial Gene Delivery Into Cornea In Vivo And In Vitro With Linearized Polyethyleneimine Nanoparticles
Author Affiliations & Notes
  • Rangan Gupta
    Ophthalmology, Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Ashish Tandon
    Ophthalmology, Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Eric T. Hansen
    Ophthalmology, Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Tyler C. Cebulko
    Ophthalmology, Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Yasaman J. Hemmat
    Ophthalmology, Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Jennifer A. Fortune
    Chemistry and Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Alexander M. Klibanov
    Chemistry and Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Rajiv R. Mohan
    Ophthalmology, Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S. Truman Veterans Administration Hospital, Columbia, Missouri
  • Footnotes
    Commercial Relationships  Rangan Gupta, None; Ashish Tandon, None; Eric T. Hansen, None; Tyler C. Cebulko, None; Yasaman J. Hemmat, None; Jennifer A. Fortune, None; Alexander M. Klibanov, None; Rajiv R. Mohan, None
  • Footnotes
    Support  VA Merit 1I01BX000357-01 (RRM), NEI RO1EY17294 (RRM), NIH RO1EB000244 (AMK) and Unrestricted Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 494. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rangan Gupta, Ashish Tandon, Eric T. Hansen, Tyler C. Cebulko, Yasaman J. Hemmat, Jennifer A. Fortune, Alexander M. Klibanov, Rajiv R. Mohan; Rapid And Substantial Gene Delivery Into Cornea In Vivo And In Vitro With Linearized Polyethyleneimine Nanoparticles. Invest. Ophthalmol. Vis. Sci. 2011;52(14):494.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Polyethyleneimine is biocompatible, biodegradable and FDA approved agent for human medical applications. The aims of this study were to test the toxicity and gene transfer efficacy of linearized PEI nanoparticles (PEI-NP) for the mouse cornea in vivo and human cornea in vitro.

Methods: : Female black C57 mice for in vivo and human stromal fibroblast (HSF) for in vitro studies were used. Transfection solution was prepared by incubating PEI-NP with plasmid (pTRUF11 expressing green fluorescent protein) in 10% glucose at 37 oC for 30 minutes. Two microliters of vehicle, PEI-NP, or transfection solution was topically applied once to the cornea of anesthetized animal for two minutes using defined hair dryer-based application technique. Mouse eyes were collected 1d, 3d, 7d, and 14d after vector application. HSF cultures were exposed to vehicle, PEI-NP, or PEI-NP-plasmid (10µl/ml medium) for 6h for in vitro investigations. Visual eye exam, and stereo- and slit-lamp biomicroscopy were used to monitor corneal health and fluorescent gene delivery in the eyes of live animals. Immunocytochemistry, western blotting, and real-time PCR techniques tested delivered transgene expression. Phase-contrast microscopy, H&E staining, trypan blue, and TUNEL assays evaluated phenotype, cellular viability, and toxicity.

Results: : Trypan blue and TUNEL assays demonstrated ≥95% cellular viability. No phonotypic changes in HSF were detected with phase-contrast microscopy. A significantly high (30-37%; p<0.01) transgene delivery was noted in HSF exposed to PEI-NP transfection solution for 6h. Slit-lamp biomicroscopy revealed no significant inflammation, redness, or opacity in PEI-NP treated corneas. However, moderate corneal haze and delayed epithelial healing were observed in few animals. PEI-NP treated mouse corneas showed substantial transgene expression in a time-dependent manner. Mouse corneal tissue section of 14d time point showed significantly higher fluorescent gene expression compared to 1d time point. Additional real-time PCR, immunocytocychemistry, western blotting, and quantification analyses are underway.

Conclusions: : Tested PEI-NP has potential for developing non-viral gene transfer approaches.

Keywords: gene transfer/gene therapy • cornea: basic science • cornea: stroma and keratocytes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×